Skip to main content

Psoriatic arthritis

RheumNow Podcast square
Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting. COSMOS: Guselkumab in TNF-IR PsA. # OP0230m Coates LC, et al. C-OPTIMISE:…
DAPSA PsA measure
Given its multiple domains, there remains much discussion over the best disease activity scoring method in PsA. The proverbial "holy grail" would be a measure that is quick, intuitive, domain…
Video: Treatment Options for PsA Patients: Dr. Paul Studenic

Dr. Paul Studenic reviews highlights from three PsA abstra

Dr. John Cush RheumNow

6 days 5 hours ago
Video: Treatment Options for PsA Patients: Dr. Paul Studenic Dr. Paul Studenic reviews highlights from three PsA abstracts - abstract op0227, abstract op0229, and abstract op0233 - presented at the virtual #EULAR2021 meeting. https://t.co/QlquUQFQOJ https://t.co/p5wBTboIpE
Psoriatic arthritis mortality & morbidities by Dr. Paul Studenic #EULAR2021

PsA is a chronic condition with manifol

Dr. John Cush RheumNow

6 days 15 hours ago
Psoriatic arthritis mortality & morbidities by Dr. Paul Studenic #EULAR2021 PsA is a chronic condition with manifold clinical presentations. Health issues may be far beyond the classical associated conditions like uveitis, enthesitis etc. https://t.co/zHfeaiiG93 https://t.co/AoHenH6YkK
Video: The PsA SpA Paradox of Choice

Dr. Rachel Tate ( @uptoTate) reviews Dr. Laura Coates' presentation Personalized T

Dr. John Cush RheumNow

1 week ago
Video: The PsA SpA Paradox of Choice Dr. Rachel Tate ( @uptoTate) reviews Dr. Laura Coates' presentation Personalized Treatment Strategies in Psoriatic Arthritis, given at the virtual #EULAR2021 meeting. https://t.co/Yg12SHR1MF https://t.co/UiCYDU5XGc
meeting.audience.3.jpg
Lots of presentations on the last day; notably, the late breaking abstracts and others. Here are a few of my favorites from Day 4. Mavrilimumab in COVID-19: LB0001– Mavrilimumab, (MAV) a human anti…
artificial intelligence machine learning computer
Subtle early bony changes in inflammatory arthritis can be hard even for experienced rheumatologists to interpret, even though they have traditionally been considered to become disease-defining as…
New GRAPPA 2021 PsO and PsA Treatment Recommendations by Dr. Rachel Tate ( @uptotate)

The evidence-based recommendation

Dr. John Cush RheumNow

1 week ago
New GRAPPA 2021 PsO and PsA Treatment Recommendations by Dr. Rachel Tate ( @uptotate) The evidence-based recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis were presented at #EULAR2021. Read more... https://t.co/AnHQGA8aKs https://t.co/4c18j4h54T
×